Concentrated Omega-3 Oils Gain in Pharmaceutical and Premium Nutrition Uses
Drug makers and premium supplement brands buy concentrated, purified fish oil with 50% to 90% EPA and DHA, and refiners add molecular distillation and enzymatic concentration to serve them. Pharmaceutical-Grade and Concentrated Omega-3 Oil grows about 8.4% a year, and gross margins run 30% to 42% against 12% to 20% for aquafeed-grade oil. The trend needs refining capacity, quality systems, and regulatory approvals. Clear specifications build buyer trust. Small refiners feel every raw material swing. Scale compounds over time. Audits repeat every year. Buyers review suppliers every season. Supply contracts decide renewal.
Market Impact: aquaculture output grows 4% yearly








